Efficacy and safety of sitagliptin for the treatment of diabetes mellitus complicated by chronic liver injury

AIM: To investigate the efficacy and safety of a dipeptidyl peptidase-4 inhibitor, sitagliptin, for treating diabetes mellitus complicated by chronic liver injury. METHODS: Sitagliptin was administered for 13.7 ± 10.1 months to 122 patients with DM complicated by chronic liver injury (including 19 p...

Descripción completa

Detalles Bibliográficos
Autores principales: Asakawa, Masahiro, Mitsui, Hiroshi, Akihisa, Momoko, Sekine, Tetsuo, Niitsu, Yoshihiro, Kobayashi, Arisa, Miyake, Atsuko, Hashimoto, Naoaki, Kawamura, Mitsunobu, Ogawa, Yoshihiro
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer International Publishing 2015
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501339/
https://www.ncbi.nlm.nih.gov/pubmed/26191473
http://dx.doi.org/10.1186/s40064-015-1135-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4501339/
https://www.ncbi.nlm.nih.gov/pubmed/26191473
http://dx.doi.org/10.1186/s40064-015-1135-z

Ejemplares similares